07:00 , Apr 10, 2014 |  BC Innovations  |  Distillery Therapeutics

Indication: Cardiovascular disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Cardiovascular disease Atherosclerosis Peroxisome proliferation-activated receptor-g (PPARG; PPARg); myeloid-lymphoma or mixed-lineage 5 (MLL5); 5ʹ-3ʹ exoribonuclease 2 (XRN2) In...